Influence of palmitoyl-3-catechin and heptyl-3-catechin on the leucocyte migration inhibition test carried out in the presence of PPD and hepatitis B surface antigen (HBsAg)

Albertini, 1977, T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B infection, Gut, 18, 1004, 10.1136/gut.18.12.1004 Aldershville, 1977, Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease, Scand. J. Gastroenterol, 12, 917, 10.3109/00365527709181350 Bassendine, 1981, Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study, Gastroenterology, 80, 1016, 10.1016/0016-5085(81)90075-5 Blum, 1977, Treatment of acute viral hepatitis with (+)-cyanidanol-3, Lancet, ii, 1153, 10.1016/S0140-6736(77)91540-9 Chadwick, 1980, Levamisole Therapy for HBsAg-Positive Chronic Liver Disease, Scand. J. Gastroenterol., 15, 973, 10.3109/00365528009181800 Clausen, 1971, Tuberculin-induced migration inhibition of human peripheral leukocytes in agarose medium, Acta Allergol., 26, 56, 10.1111/j.1398-9995.1971.tb01399.x Cochrane, 1976, Antibody dependent cell-mediated cytotoxicity against isolated hepatocytes in chronic active hepatitis, Lancet, ii, 441, 10.1016/S0140-6736(76)91472-0 Czaja, 1981, Corticosteroid-treated chronic active hepatitis in remission. Uncertain prognosis of chronic persistent hepatitis, New Engl. J. Med., 304, 5, 10.1056/NEJM198101013040102 Desaules, 1976, Lack of leucocyte migration inhibition by hepatitis B antigen and normal non specific immuno-reactivity in 25 asymptomatic carriers of this antigen, J. infect. Dis., 134, 505, 10.1093/infdis/134.5.505 Erard, 1974, Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen, Clin. exp. Immunol., 18, 439 Frei, 1973, Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocytes migration test during and after acute hepatitis, Biomed. Express, 19, 379 Frei, 1978, Cell-mediated immune response to purified HBsAg in HBV infection, 267 Giuliani-Piccari, 1979, Levamisole therapy in chronic active liver diseases, 345 Kappus, 1981, (+)-cyanidanol-3 inhibition of lipid peroxidation induced by hepatotoxic chemicals in the rat, 17 McLean, 1978, An in vitro model of liver injury using paracetamol treatment of liver slices and prevention of injury by some antioxidants, Biochem. Pharmacol., 27, 425, 10.1016/0006-2952(78)90371-4 Merigan, 1979, Human interferon as a therapeutic agent, New Engl. J. Med., 300, 43, 10.1056/NEJM197901043000113 Niebes, 1975, Stabilisation of rat liver lysosomes by cyanidanol-3 in vivo, Biochem. Pharmac., 24, 905, 10.1016/0006-2952(75)90162-8 Perrissoud, 1981, A morphological and biochemical study of the interaction of (+)-cyanidanol-3 with the plasma membrane and protection against phalloidin and CC14 toxicity in isolated rat hepatocytes, 21 Ryle, 1983, A comparative study of the effect of (+)-catechin and 3-palmitoyl-(+)-catechin on alcoholic fatty liver in the rat, Alcohol Alcoholism, 18, 239 Schulman, 1979, A double-blind-evaluation of transfer factor therapy of HBsAg positive chronic aggressive hepatitis: preliminary report of efficacy, Cell. Immun., 43, 352, 10.1016/0008-8749(79)90179-5 Siegers, 1981, Antihepatotoxic activity of (+)-cyanidanol-3 in acute and chronic experimental livery injury, 19 Vallotton, 1981, Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen, Infect. Immun., 32, 432, 10.1128/IAI.32.2.432-437.1981 Vido, 1980, Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis, Deutsche Med. Wschr., 105, 330, 10.1055/s-2008-1070660 Weimar, 1980, Double-blind study of leucocyte interferon administration in chronin HBsAg-positive hepatitis, Lancet, i, 336, 10.1016/S0140-6736(80)90885-5 Weisbart, 1977, A microassay for leucocytes migration: analysis of its reproducibility, J. Immun. Methods, 16, 269, 10.1016/0022-1759(77)90204-6 Wright, 1977, Treatment of chronic active hepatitis. An analysis of these controlled trials, Gastroenterology, 74, 1422, 10.1016/S0016-5085(19)31527-6 Yeung Laiwah, 1973, Lymphocyte transformation and leucocyte migration inhibition by Australian antigen, Clin. exp. Immun., 15, 27